India Oligonucleotide Synthesis Market (2025-2030)
The India Oligonucleotide Synthesis Market was valued at $197.3 Million in 2025 and projected to reach to $474.2 Million by 2030, representing a compound annual growth rate of 19.2%. India's oligonucleotide synthesis market is poised for exceptional growth, driven by expanding genomic medicine initiatives, increasing prevalence of genetic disorders, and the country's emergence as a cost-competitive manufacturing destination.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Oligonucleotide Synthesis Market Trends and Insights
- India is emerging as a critical hub for oligonucleotide manufacturing and research, driven by increasing investments in genomic medicine, rising prevalence of genetic disorders, and growing adoption of personalized therapeutics across the country.
- The market in India benefits from a strong pharmaceutical and biotechnology ecosystem, cost-competitive manufacturing capabilities, and government initiatives supporting life sciences innovation. India's oligonucleotide synthesis sector is positioned to capture significant market share within the Asia Pacific region, supported by expanding research institutions, contract manufacturing organizations (CMOs), and growing demand from domestic and international pharmaceutical companies.
- The forecast period through 2030 reflects India's strategic importance in the global oligonucleotide supply chain, with accelerating clinical applications in oncology, rare genetic diseases, and infectious disease therapeutics.
- India's skilled workforce, regulatory improvements, and infrastructure development are expected to sustain this high-growth trajectory throughout the forecast period..
Key Market Statistics
- CAGR (2025-2030) 19.2% CAGR
- Market Size, 2025 ~USD 197.3 Million
- Forecast, 2030 ~USD 474.2 Million
- Country India
India Oligonucleotide Synthesis Market Overview
Rapid Market Expansion :
India's oligonucleotide synthesis market is growing at 19.2% CAGR, outpacing the global rate of 18.6%, driven by increasing adoption of gene therapies and personalized medicine initiatives across the country.
Manufacturing Hub Status :
India is establishing itself as a critical global hub for oligonucleotide manufacturing, leveraging cost-effective production capabilities, skilled workforce, and favorable regulatory environment to attract international investments.
Genomic Medicine Investments :
Significant government and private sector investments in genomic research infrastructure, coupled with rising prevalence of genetic disorders, are accelerating demand for oligonucleotide synthesis technologies and services.
Projected Market Growth :
Market valuation is expected to more than double from USD 197.3 million in 2025 to USD 474.2 million by 2030, reflecting strong momentum in therapeutic development and diagnostic applications.
India Oligonucleotide Synthesis Market Dynamics
- Government support for biotechnology development, coupled with rising healthcare investments and growing pharmaceutical R&D activities, creates a favorable ecosystem for market expansion.
- The market's 19.2% CAGR reflects strong demand from both domestic and international players seeking to leverage India's manufacturing capabilities and research expertise in oligonucleotide-based therapeutics and diagnostics. Key growth catalysts include the establishment of specialized manufacturing facilities, collaborations between Indian biotech companies and global pharmaceutical firms, and increasing clinical trials for oligonucleotide-based treatments.
- Rising awareness of personalized medicine and genetic testing, combined with improving healthcare infrastructure and regulatory frameworks, will further accelerate market penetration.
- India's competitive advantage in cost-effective production positions it as a preferred destination for contract manufacturing and research outsourcing in the oligonucleotide synthesis sector..
Related Ecosystem
Biotechnology
Key Takeaways
- India's oligonucleotide synthesis market is valued at USD 197.3 million in 2025 and is forecast to grow to USD 474.2 million by 2030, driven by a 19.2% CAGR.
- India is establishing itself as a key manufacturing and research hub for oligonucleotides in Asia Pacific, leveraging cost advantages and skilled talent.
- Growing demand for personalized medicine, genomic research, and therapeutic applications in India is accelerating market expansion.
- India's regulatory environment, infrastructure development, and government support for biotechnology are critical enablers of sustained market growth through 2030.
Oligonucleotide Synthesis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 18.6% from 2025 to 2030 |
| Market Size Base Year (Billions) | ~USD 10.53 (2025) |
| Revenue Forecast (Billions) | ~USD 24.7 (2030) |
| Segments Covered | Product, Type, Application, Disease Type, End User |
India Oligonucleotide Synthesis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Dna Oligos
- Equipment
- Oligonucleotide-Based Drugs
- Other Synthesized Oligos
- Primers
- Probes
- Reagents & Consumables
- Rna Oligos
- Synthesized Oligonucleotides
By Type
- Antisense Oligonucleotide-Based-Drugs
- Custom Oligonucleotides
- Other Oligonucleotide-Based-Drugs
- Other Research Applications
- Pcr
- Predesigned Oligonucleotides
- Sequencing
- Sirna Oligonucleotide-Based-Drugs
By Application
- Diagnostic Applications
- Research Applications
- Therapeutic Applications
By Disease Type
- Neurological Disorders
- Other Diseases
- Rare Diseases
By End User
- Academic Research Institutes
- Cros & Cmos
- Diagnostic Laboratories
- Hospitals
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical & Biotech Companies : Require India-specific market data to evaluate manufacturing partnerships, contract research opportunities, and market entry strategies in the rapidly expanding oligonucleotide synthesis sector.
- Contract Manufacturing Organizations (CMOs) : Need detailed market insights to assess growth potential, competitive positioning, and capacity expansion opportunities in India's emerging oligonucleotide manufacturing ecosystem.
- Investment & Private Equity Firms : Seek India market intelligence to identify high-growth investment opportunities, evaluate portfolio companies' market potential, and guide capital allocation in the genomic medicine and biotech sectors.
- Healthcare & Diagnostic Companies : Require market data to understand demand for oligonucleotide-based diagnostics, personalized medicine applications, and genetic testing services in India's growing healthcare market.
- Government & Policy Organizations : Need market analysis to inform biotechnology policy, research funding decisions, and regulatory frameworks supporting India's development as a global oligonucleotide synthesis hub.
Key Companies in the India Oligonucleotide Synthesis Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| FLUOR CORPORATION | United States | Public Company | Energy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining, infrastructure, staffing, maintenance),Mission Solutions (government, nuclear remediation, security, logistics, O&M), |
FLUOR CORPORATION
Fluor Corporation is a publicly traded engineering and construction company founded in 1912 and headquartered in the United States. With approximately 23,000 employees, the company provides design, engineering, procurement, and construction services across multiple industries.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India (USD 197.3M in 2025) with verified 19.2% CAGR projections through 2030, enabling accurate business planning and investment decisions in the Indian oligonucleotide sector.
- Competitive Landscape Intelligence : Understand India's positioning as an emerging manufacturing hub relative to global markets, identifying opportunities to establish or expand operations in a high-growth, cost-competitive region with favorable regulatory conditions.
- Investment & Partnership Opportunities : Identify strategic investment targets, joint venture prospects, and partnership opportunities with Indian biotech firms capitalizing on the country's rapid market expansion and manufacturing capabilities.
- Regulatory & Market Entry Insights : Access India-specific regulatory frameworks, compliance requirements, and market entry strategies essential for pharmaceutical companies, contract manufacturers, and research organizations planning operations in India.
- Demand Drivers & Growth Catalysts : Analyze India-specific factors driving market growth including genetic disorder prevalence, government genomic initiatives, healthcare investments, and clinical trial activities to forecast demand and optimize market strategies.
Frequently asked questions
What is the current size of India's oligonucleotide synthesis market?
India's oligonucleotide synthesis market is valued at USD 197.3 million in 2025 and is expected to grow significantly through the forecast period.
What is the projected market size for India's oligonucleotide synthesis market by 2030?
India's oligonucleotide synthesis market is projected to reach USD 474.2 million by 2030, representing substantial growth from the 2025 baseline.
What is the CAGR for India's oligonucleotide synthesis market?
India's oligonucleotide synthesis market is expected to grow at a compound annual growth rate of 19.2% between 2025 and 2030.
What factors are driving growth in India's oligonucleotide synthesis market?
Key drivers include increasing investments in genomic medicine, rising prevalence of genetic disorders, growing adoption of personalized therapeutics, and government support for biotechnology innovation in India.
Why is India important for the global oligonucleotide synthesis market?
India offers cost-competitive manufacturing, a skilled workforce, expanding research infrastructure, and strategic positioning within Asia Pacific, making it a critical hub for global oligonucleotide supply chains.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global oligonucleotide synthesis market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify and collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, the World Health Organization (WHO), the United States Food and Drug Administration (US FDA), the National Center for Biotechnology Information (NCBI), and regulatory body websites, among others. These sources also provided key information on major players, market classification and segmentation aligned with industry trends, regional and country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the oligonucleotide synthesis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Oligonucleotide Synthesis Market : Top-Down and Bottom-Up Approach
Data Triangulation
After determining the overall market size through the estimation process, the total market was segmented into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Oligonucleotide synthesis is the chemical process of creating nucleic acid fragments with specific chemical structures or sequences, of varying sizes, to form a desired product. These fragments, known as oligonucleotides, have several applications in medical and life science research. They can be used for DNA sequencing and amplification, detecting complementary DNA or RNA through hybridization, creating artificial genes, and introducing targeted genetic mutations.
Oligonucleotides are also used to develop therapeutic drugs. These drugs are chemically synthesized and have different mechanisms of action, such as interfering with gene expression, blocking the production of harmful proteins, or restoring the function of mutated genes.
Key Stakeholders
- Pharmaceutical & biotechnology companies
- Hospitals
- Diagnostic laboratories
- Academic researchers and government research organizations
- Private research institutes
- Custom oligonucleotide service providers
- Contract manufacturing organizations (CMOs)
- Oligonucleotide equipment manufacturers
- Contract research organizations (CROs)
- Market research & consulting firms
- Venture capitalists
Report Objectives
- To define, describe, and forecast the global oligonucleotide synthesis market based on the offering, type, application, end user, therapeutic area, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall oligonucleotide synthesis market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the oligonucleotide synthesis market
- To provide information on funding & investment activities, brand/product comparative analysis, vendor valuation, and financial metrics of the oligonucleotide synthesis market
Available customizations:
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix gives a detailed comparison of the product portfolios of the top five companies.
Geographical Analysis
- A further breakdown of the Rest of Europe’s oligonucleotide synthesis market into countries
- A further breakdown of the Rest of Asia Pacific’s oligonucleotide synthesis market into countries
- A further breakdown of the Rest of Latin America’s oligonucleotide synthesis market into countries
- A further breakdown of the Rest of Middle East’s oligonucleotide synthesis market into countries
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Get the Full Oligonucleotide Synthesis Market Report
Full forecast, segment splits, and company analysis for all Oligonucleotide Synthesis Market.
- US Oligonucleotide Synthesis Market
- Canada Oligonucleotide Synthesis Market
- Germany Oligonucleotide Synthesis Market
- UK Oligonucleotide Synthesis Market
- France Oligonucleotide Synthesis Market
- Italy Oligonucleotide Synthesis Market
- Spain Oligonucleotide Synthesis Market
- China Oligonucleotide Synthesis Market
- Japan Oligonucleotide Synthesis Market
- Australia Oligonucleotide Synthesis Market
- South Korea Oligonucleotide Synthesis Market
- Brazil Oligonucleotide Synthesis Market
- Mexico Oligonucleotide Synthesis Market
- Argentina Oligonucleotide Synthesis Market
- Saudi Arabia Oligonucleotide Synthesis Market
- United Arab Emirates Oligonucleotide Synthesis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report